Edwards Lifesciences Corporation Common Stock vs Ingersoll Rand — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Ingersoll Rand trades at $78.16 (market cap $29.97B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Ingersoll Rand pays a 0.1% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | IR | |
|---|---|---|
Market Cap | $49.44B | $29.97B |
Volume | 3,508,027 | 4,688,805 |
Sector | Health | Industrials |
52-Week High | $95.18 | $98.76 |
52-Week Low | $72.65 | $68.54 |
Enterprise Value | $45.90B | $33.63B |
Typical Hold Time | — | 7 Days |
Dividend Yield | — | 0.1% |
Trailing returns across standard periods
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →